A Topical Depigmentation Program Against Hyperpigmentation Enhances the Benefits of Previously Performed Chemical Peeling Procedures of the Face.


Journal

Journal of cosmetic science
ISSN: 1525-7886
Titre abrégé: J Cosmet Sci
Pays: United States
ID NLM: 9814276

Informations de publication

Date de publication:
Historique:
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 30 1 2021
Statut: ppublish

Résumé

Chemical peeling can reduce skin hyperpigmentation; however, once exhausted its thinning action, the depigmentation process does not continue further. We carried out a monocentric, prospective, noncontrolled study aimed at the evaluation of the efficacy, safety, ease of use, pleasantness, and tolerability of a depigmentation topical treatment program in women submitted to a previous chemical peeling. The topical treatment has been administered daily for 30 days to 16 women submitted to a chemical peeling containing a fixed-dose combination of salicylic acid, pyruvic acid, and retinoic acid within 7 days before study inclusion. Target skin areas have been evaluated for melanin concentration and skin texture before peeling and at study visits 1 (after peeling) and 2 (after the 30-day treatment). The topical treatment program induced a decrease in melanin concentration between study visits 1 and 2 (-4.74%;

Identifiants

pubmed: 33413783

Substances chimiques

Skin Lightening Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-397

Auteurs

Maurizio Cavallini (M)

Unit of Dermatology and Dermatosurgery, CDI Hospital, Milan 20124, Italy (M.C., M.P.), Statistics and Data Management Unit, Latis S.r.l., Genova 16121, Italy (F.M.).

Fabio Montanaro (F)

Unit of Dermatology and Dermatosurgery, CDI Hospital, Milan 20124, Italy (M.C., M.P.), Statistics and Data Management Unit, Latis S.r.l., Genova 16121, Italy (F.M.).

Marco Papagni (M)

Unit of Dermatology and Dermatosurgery, CDI Hospital, Milan 20124, Italy (M.C., M.P.), Statistics and Data Management Unit, Latis S.r.l., Genova 16121, Italy (F.M.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH